Skip to content

Medpace Holdings, Inc. MEDP Other accrued liabilities

Other accrued liabilities at other companies

Medline, Inc.
 logo
Medline, Inc. MDLN
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Guardant Health logo
Guardant HealthGH
SS&C Technologies logo
SS&C TechnologiesSSNC

Other financials

Income statement

See full
Revenue$706.6M+26.5%
Operating income$141.5M+24.6%
Net income$123.9M+8.1%
EPS (diluted)$4.28+16.6%

Balance sheet

See full
Cash & equivalents$652.7M+47.9%
Total debt$146.1M-2.8%
Total equity$598.3M+0.8%
Total assets$2.1B+12.2%

Cash flow

See full
Operating cash flow$151.8M+20.6%
CapEx$6.8M-31.8%
Free cash flow$145.0M+25.1%

Valuation

See full
Market cap$13.14B+46.8%
Enterprise value$12.64B+45.9%
P/E28.6×+7.0×
P/S4.9×+0.8×

Profitability

See full
Operating margin21%-0.1pp
Net margin17.2%-2.1pp
FCF margin26.5%+1.5pp

Returns & leverage

See full
Return on equity77.3%+11.4pp
Debt / equity0.2×0.0×
Current ratio0.8×+0.1×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.

The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medpace Holdings, Inc.'s other accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medpace Holdings, Inc.'s other accrued liabilities?
Medpace Holdings, Inc. (MEDP) reported other accrued liabilities of $11.61M in Q1 2026.
How has Medpace Holdings, Inc.'s other accrued liabilities changed year-over-year?
Medpace Holdings, Inc.'s other accrued liabilities decreased by 1.9% year-over-year, from $11.83M to $11.61M.
What is the long-term trend for Medpace Holdings, Inc.'s other accrued liabilities?
Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s other accrued liabilities has grown at a 6.2% compound annual growth rate (CAGR), from $9.6M to $12.23M.